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Productive infection by human immunodeficiency virus type I (HIV-1) in the central nervous system (CNS) involves mainly macrophages
and microglial cells. A frequency of less than 10% of human astrocytes is estimated to be infectable with HIV-1. Nonetheless, this relatively
low percentage of infected astrocytes, but associated with a large total number of astrocytic cells in the CNS, makes human astrocytes a
critical part in the analyses of potential HIV-1 reservoirs in vivo. Investigations in astrocytic cell lines and primary human fetal astrocytes
revealed that limited HIV-1 replication in these cells resulted from low-level viral entry, transcription, viral protein processing, and virion
maturation. Of note, a low ratio of unspliced versus spliced HIV-1-specific RNAwas also investigated, as Rev appeared to act aberrantly in
astrocytes, via loss of nuclear and/or nucleolar localization and diminished Rev-mediated function. Host cellular machinery enabling Rev
function has become critical for elucidation of diminished Rev activity, especially for those factors leading to RNA metabolism. We have
recently identified a DEAD-box protein, DDX1, as a Rev cellular co-factor and now have explored its potential importance in astrocytes.
Cells were infected with HIV-1 pseudotyped with envelope glycoproteins of amphotropic murine leukemia viruses (MLV). Semi-quantitative
reverse transcriptase-polymerase chain reactions (RT-PCR) for unspliced, singly-spliced, and multiply-spliced RNA clearly showed a lower
ratio of unspliced/singly-spliced over multiply-spliced HIV-1-specific RNA in human astrocytes as compared to Rev-permissive, non-glial
control cells. As well, the cellular localization of Rev in astrocytes was cytoplasmically dominant as compared to that of Rev-permissive,
non-glial controls. This endogenous level of DDX1 expression in astrocytes was demonstrated directly to lead to a shift of Rev sub-cellular
distribution dominance from nuclear and/or nucleolar to cytoplasmic, as input of exogenous DDX1 significantly altered both Rev sub-cellular
localization from cytoplasmic to nuclear predominance and concomitantly increased HIV-1 viral production in these human astrocytes. We
conclude that altered DDX1 expression in human astrocytes is, at least in part, responsible for the unfavorable cellular microenvironment for
Rev function in these CNS-based cells. Thus, these data suggest a molecular mechanism(s) for restricted replication in astrocytes as a
potential low-level site of residual HIV-1 in vivo.
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HIV-1 frequently infects the CNS of individuals soon after
seroconversion (Resnick et al., 1988; Spector et al., 1993).
Studies have demonstrated that microglia and monocyte/
macrophages are major cellular reservoirs for highly pro-0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Gabuzda et al., 1986; Gosztonyi et al., 1994; Kure et al.,
1990; Resnick et al., 1988). As well, HIV-1 replication has
been evaluated in some detail within human fetal and adult
astrocytes both in vitro and in vivo (Bagasra et al., 1996;
Nuovo et al., 1994; Ranki et al., 1995; Sabri et al., 1999; Saito
et al., 1994; Tornatore et al., 1994a). These studies suggest a
restricted form of HIV-1 replication in astrocytic cells
characterized mainly by expression of multiply-spliced05) 299 – 307
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products (e.g., Rev, Tat, and especially Nef) (Ranki et al.,
1995; Saito et al., 1994; Tornatore et al., 1994a), although this
remains controversial (Canki et al., 2001).
HIV-1 infection in astrocytes has several unusual para-
meters and mechanisms. Human astrocytes have been
demonstrated to allow CD4-independent infection with
HIV-1, and a recent study has suggested that the human
mannose receptor is critical in this entry (Liu et al., 2004), but
astrocytes do have functional chemokine receptors (Dorf et
al., 2000). HIV-1 expression and transcription may be
profoundly different in human astrocytes as compared to
human T-lymphocytes (Coyle-Rink et al., 2002; Overholser
et al., 2003). Of note, MCP-1, a pro-inflammatory chemo-
kine, may be increased by HIV-1 Tat in human astrocytic glial
cells (Abraham et al., 2003), and Tat appears to improve
astrocyte survival (Chauhan et al., 2003). Data have also
suggested that glutamate transport may be altered in human
astrocytes exposed to HIV-1 virions or gp120 (Wang et al.,
2003), and subtraction hybridization plus microarray analy-
ses have demonstrated differences in transcriptional regu-
lation in human astrocytes exposed to HIV-1 or isolated
gp120 (Galey et al., 2003; Su et al., 2003; Wang et al., 2004).
Persistent HIV-1 infection was initially demonstrated to
occur in human fetal astrocytes, which could also be
reactivated by various pro-inflammatory cytokines to
productive infection, including tumor necrosis factor-alpha
(TNF-a) and interleukin-I (IL-I) (Atwood et al., 1994;
Tornatore et al., 1991, 1994b). Initial studies suggested that
in human astrocytes at least one relative block to highly
productive infection was inefficient viral entry (Canki et al.,
2001; Kunsch et al., 1989; Liu et al., 2004; Schweighardt
and Atwood, 2001). As well, other studies suggested that
there might be transcriptional inefficiency of long terminal
repeat (LTR)-mediated regulation of viral gene expression
(Brack-Werner et al., 1992), as we demonstrated in certain
astrocytic cell lines (Niikura et al., 1996). Nonetheless, an
over-expression in multiply-spliced viral RNAs, out of
proportion to unspliced and singly-spliced viral messages,
has been demonstrated by various laboratories in both
astrocytic cell lines and primary human astrocytes (Gorry et
al., 1999; Kleinschmidt et al., 1994; Kohleisen et al., 1992).
This is a pattern consistent with a Rev-negative or more
accurately, a Rev-impaired phenotype, which has begun to
be more fully characterized in recent studies (Ludwig et al.,
1999; Neumann et al., 1995). These findings suggested that
this cell type was the first clear example of a dysfunctional
Rev response in human cells, leading to an alteration in
post-transcriptional control of HIV-1 gene expression
(Ludwig et al., 1999).
In a recent article (Neumann et al., 2001), both astrocytic
cell lines and primary human fetal astrocytes were evaluated
for nucleocytoplasmic transport of HIV-1 Rev. In the vast
majority of human cells, Rev is a shuttling protein which is
transported from the cytoplasm to the nucleus and returns as
the major factor shuttling unspliced HIV-1 RNA from thenucleus of infected cells (Kjems and Askjaer, 2000). These
investigators demonstrated that there is a dramatic shift in
the level of cytoplasmic as compared to nuclear Rev in
astrocytes, with a Rev-deficient viral RNA phenotype
characterized by multiply-spliced out of proportion to
unspliced viral RNA species (Neumann et al., 2001). In
primary astrocytic cells, it was demonstrated that there was a
remarkable over-abundance of Rev in the cytoplasm, which
did not transport properly into the nucleus, and that nuclear
uptake of Rev was impaired specifically. The authors
hypothesized that there was a cytoplasmic cellular ‘‘activity’’
that interfered with nuclear uptake of Rev (Neumann et al.,
2001). This is important as these are the first initial data on a
clear molecular mechanism of HIV-1-impaired production
and persistence in a human CNS-based cell type.
Data from Li et al. (2002) have demonstrated that the
impaired Rev function in astrocytes may be at least partially
alleviated with over-expression of SAM68, the 68-kDa Src-
associated protein in mitosis. Of note, though, these studies
were performed only in an astrocytic glial cell line, without
clear analyses of primary astrocytes, U87.MG.
The differences described in HIV-1 restriction mecha-
nisms in astrocytes, demonstrated in studies from several
experienced laboratories, may be based on several potential
factors. They include potential multiple levels and mecha-
nisms of HIV-1 restriction in the viral life-cycle in astrocytic
cells, difference in stages of cell development, differ-
entiation, or culture conditions used in each study, and/or
differences in levels and infectivity of viral input challenges,
possibly when utilizing robust viral pseudotypes.
In a high throughput search for cellular factors interact-
ing with the nuclear diffusion inhibitory signal (NIS) motif
of the N-terminus of Rev, we identified a DEAD-box (Asp–
Glu–Ala–Asp) RNA helicase, DDX1 (Fang et al., 2004).
NIS-deficient mutant Rev has a cytoplasmic dominance in
Rev-permissive cells, which is similar to the phenotype of
intact Rev in astrocytic cells (Fang et al., 2002; Kubota and
Pomerantz, 1998; Neumann et al., 2001). We hypothesized
that, in astrocytes, alteration of cellular factor(s) interacting
with Rev NIS motif leads to an impaired Rev functional
status. We demonstrate in this report that DDX1 expression
is closely correlated to Rev function in primary astrocytes,
with DDX1 over-expression in human astrocytes both
normalizing sub-cellular localization of Rev and potently
augmenting HIV-1 replication. Therefore, an alteration of
DDX1 expression is likely involved in the unique cellular
microenvironment of astrocytes.Results
Ratios of spliced to unspliced HIV-1-specific RNA suggest
altered splicing machinery in human astrocytes
HIV-1 inefficiently infects astrocytic cell lines and
primary astrocytes, and entry is one clear block towards
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block by applying pseudotyped HIV-1 to cultures of primary
human astrocytes, as reported previously (Canki et al.,
2001).
The purity of human primary fetal astrocytes was
confirmed by Cy3-conjugated anti-glial fibrillary acidic
protein (GFAP) staining (Fig. 1A). Virus input was
optimized to a total amount of 10 ng of p24 Gag at a
concentration of 50 ng of p24 antigen per milliliter of
culture medium, under which reproducible low-levels of
produced virions were demonstrable in the medium of
astrocytes, as compared to non-glial HeLa cells (Fig. 1B).
With previous studies suggesting the restriction of HIV-1 in
astrocytes, we analyzed viral mRNA splicing patternFig. 1. Accumulation of multiply-spliced HIV-1 mRNA in primary human astrocy
seeded in slide chambers were stained with Cy3-conjugated, anti-GFAP antibody
over 50% confluence, as shown in this figure, were used for infection experime
(MLV) envelope of astrocytes and HeLa cells. For detailed infection procedures,
experiments. (C) Detection of unspliced HIV-1 genomic RNA, multiply-spliced, an
extracted from the HIV-1NL4-3 infected astroglial cell line, U87.MG, followed by
diluent in the limiting dilution series. The control PCR primers, for the 361-bp
combined with primers for amplification of viral RNAs in the same reactions. The
bp, respectively. (D) Unspliced, multiply-spliced, and singly-spliced viral RNA in p
or wild-type HIV-1NL4-3. Human fetal astrocytes and HeLa cells in 24-well plate
samples on the next day after infection were used for detection of pol, representativ
spliced viral RNA, and BSS-KPNA for singly-spliced viral RNA (from top to bott
density ratios, from duplicates. A, Astrocytes; H, HeLa cells.changes by using a newly-developed semi-quantitative RT-
PCR (Fig. 1C). The unspliced pol RNA and singly-spliced
RNA (BSS-KPNA) representatives in astrocytes were
¨30% of that in HeLa cells at a wide range of viral input
levels (Fig. 1D, top and bottom panels). In contrast, the
multiply-spliced RNA, tat –rev and tat–rev –nef, demon-
strated 30–100% higher relative amounts in human
astrocytes over those found in infected HeLa cells (Fig.
1D, 2nd and 3rd panels). We also investigated HIV-1-
specific RNAs from day 3 samples and high viral input
doses (>1.0 Ag/ml, total >200 ng p24 equivalents of virus).
In these studies, there was no relative difference found for
the various RNA species between astrocytes and HeLa cells
(data not illustrated), which suggests that the Rev-basedtes. (A) GFAP expression in human fetal astrocytes. Human fetal astrocytes
(left), or with Cy3-anti-mouse IgG (right), as a control. The astrocytes with
nts. (B) Infection by pseudotyped HIV-1NL4-3 with murine leukemia virus
see Materials and methods. The data are representative of two independent
d singly-spliced viral RNA in limiting dilution series. The cellular RNAwas
reverse transcription and PCR. Mouse cDNA from liver RNA served as a
fragment of ‘‘housekeeping’’ gene S15 of both human and mouse, were
sizes for pol, tat – rev, and tat – rev –nef amplicons were 196, 173, and 146
rimary human fetal astrocytes and HeLa cells with infection of pseudotyped
s were infected with pseudotyped HIV-1NL4-3 with an MLV envelope. Cell
e of unspliced HIV-1 genomic RNA, tat – rev and tat – rev –nef for multiply-
om panels), respectively. The numbers under each panel are mean values of
Fig. 2. DDX1 cellular distribution in astrocytes. (A) Endogenous cellular
DDX1 in astrocytes (left panel) and HeLa cells (right panel), using indirect
immunofluorescence staining and microscopy (see Materials and methods),
with DAPI staining (bottom) showing nuclear regions. (B) Expression of
Rev-GFP fusion protein in primary human astrocytes and HeLa cells
(upper) with DAPI staining (bottom; for details, see Materials and
methods).
Fig. 3. Additional exogenous DDX1 expression partially restores Rev
nuclear localization in astrocytes. Astrocytic cells were transfected with the
Rev-GFP expression vector, alone (A) or with pcDDX1 (B). As a control,
the GFP expression vector alone (i.e., No Rev fusion; C), or with pcDDX1
(D), was used. Left and right panels show green fluorescence and nuclear
DAPI staining, respectively. The total transfection input was normalized
with pcDNA.
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but rather a Rev-impaired phenotype, which can be
evaluated only under certain input virus limits. We conclude
that alteration in HIV-1 mRNA splicing machinery occurs in
pseudotyped HIV-1NL4-3-infected astrocytes. Thus, cell-
type-specific cellular factor(s) may contribute towards
post-transcriptional regulation of HIV-1 production in
primary astrocytes.
DDX1 is both nuclear and cytoplasmically expressed and
HIV-1 rev is cytoplasmically dominant in human astrocytes
As DDX1 was identified as a Rev-interacting protein and
Rev was suggested to have cytoplasmic dominance in
astrocytes, we first investigated DDX1 sub-cellular distri-bution in the U87MG astrocytoma cell line, primary human
fetal astrocytes, and the non-glial Rev-permissive HeLa
cells, as a negative control.
While HeLa cells maintain most DDX1 in the nucleus,
both the astrocytic cell line and primary human astrocytes
demonstrated some cytoplasmic localization (Fig. 2A). The
Rev-green fluorescence protein (GFP) fusion protein in the
astrocytic cell line, primary human astrocytes, but not HeLa
cells, had mainly cytoplasmic sub-cellular compartmental-
ization (Fig. 2B). The approximate sub-cellular localizations
of DDX1 and HIV-1 Rev in control and experimental
groups suggest that cytoplasmic dominance of Rev in
astrocytes potentially could be related to DDX1 compart-
mentalization in these cell types, but distinctive and relative
quantitative levels of DDX1 are also likely operational, and
associate with aberrant Rev sub-cellular compartmentaliza-
tion and diminished Rev function in these cells.
Of importance, over-expression of exogenous DDX1 in
astrocytic cells induced certain astrocytic cells to demon-
strate wild-type nuclear-predominant Rev-GFP localization,
while GFP alone remained evenly distributing, including
significant cytoplasmic expression (Fig. 3). The reversal of
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basal level of endogenous DDX1 expression, at least
relative for astrocytes, may negatively affect Rev function
in astrocytes by altering Rev localization.
DDX1-linked alterations of HIV-1 replication in astrocytes
Next, we analyzed if directly altering DDX1 in
astrocytes would effect HIV-1 expression. We first showed
a specific inhibition of HIV-1 replication by small
interfering RNA (siRNA) to DDX1 in astrocytic U87MG
cells (Fig. 4A). The efficacy and specificity of siRNA to
DDX1 were demonstrated previously (Fang et al., 2004).Fig. 4. (A) Further inhibition of HIV-1 replication by down-modulating
DDX1 in astrocytic cells. U87CD4/X4 cells seeded in 24-well plates (1105
cells/well) were transfectedwith siRNADDX1 or control siRNAGFP at 0.04
Am. Six hours after siRNA transfection, the cells were treated with freshly
prepared HXB-luc virus (10 ng of p24 antigen) for overnight infection. After
washing, the cells were then treated with lysing buffer and luciferase activity
was assayed. (B) Augmentation by exogenous DDX1 of HIV-1 replication in
primary human astrocytes. Transfections of pNL4-3 alone or with the DDX1
expression vector were performed in primary human astrocytes. The HIV-1
p24 antigen levels ( y-axis) in the supernatant of cultured cells weremeasured
on the third day after transfection. The numbers in the x-axis represent
micrograms of DDX1 expression plasmid transfected in each well of a
12-well plate, without (NC, negative control) or with 0.17 Ag of pNL4-3 by
co-transfection. A total of 0.5 Ag DNA, supplemented by pcDNA3.0, was
transfected in each well. The data were derived from triplicate experiments
with one standard deviation (SD). The symbol ‘‘*S’’ denotes a statistical
significance between groups ‘‘pNL4-3 only’’ and ‘‘+DDX1 0.33’’ by using
the Student–Newman–Keul method with a significance level of 5% via
Statview software.Approximately 90% inhibition of HIV-1 replication was
observed in the siRNA DDX1 group, as compared to the
control siRNA green fluorescence protein (GFP) group,
demonstrating a potent role for DDX1 in HIV-1 replication
in human astrocytic cells. A further confirmation of
DDX1’s effects on HIV-1 replication in astrocytes was
obtained from co-transfection of a DDX1 expression
vector with pNL4-3 in primary human astrocytes, demon-
strating significantly augmented HIV-1 p24 Gag produc-
tion in a relatively dose-dependant manner (Fig. 4B).
These experiments by-passed low viral entry and directly
interdicted in the cellular environment of astrocytes with
exogenous DDX1 expression. Therefore, we conclude,
based on these data and those illustrated in Fig. 3, that
over-expression of DDX1 functions to induce a more
favorable intracellular astrocytic microenvironment, which
at baseline is semi-restrictive for replication of HIV-1.Discussion
Wild-type HIV-1 Rev function requires nuclear and/or
nucleolar localization of Rev based on a number of reports
using mutational and functional approaches (Hope et al.,
1992; Kubota and Pomerantz, 1998; Ludwig et al., 1999;
Malim et al., 1989). In primary human astrocytes or certain
astrocytic cell lines, Rev shifts from nuclear to cytoplasmic
dominance, and this was suggested to be one of a multi-
step process which leads to limited HIV-1 replication in
astrocytes (Brack-Werner et al., 1992; Li et al., 2002;
Neumann et al., 1995). These stages include restriction in
entry, viral transcription, splicing, Rev-dependant RNA
transport, and translation (Brack-Werner, 1999; Gorry et
al., 2003; Wang et al., 2004). In this report, we
demonstrate that when pseudotyped HIV-1 infection by-
pass entry restriction, decreased ratios of unspliced over
spliced transcripts developed as an indicator of relative
Rev functional inefficiency. A fully functional Rev protein
thus requires both critical Rev domains or motifs and
specific interacting cellular factors.
The cytoplasmic dominance of Rev distribution in
astrocytes was previously shown to retard Rev uptake into
the nucleus in a study analyzing dynamic nucleocytoplas-
mic trafficking of Rev (Neumann et al., 2001). This
phenotype of Rev in astrocytic cells, confirmed and
extended by our laboratories in the present study, was
profoundly similar in terms of cytoplasmic dominance to
that of a Rev mutant with deletion of the NIS signal in
Rev-permissive cells, as demonstrated in our laboratories
(Adachi et al., 1986; Fang et al., 2002). This similarity led
us to investigate in astrocytes the NIS-interacting protein
DDX1, a DEAD-box RNA helicase for involvement in this
altered Rev axis.
The DDX1 gene expresses variably in different cell types
(Godbout et al., 1998). While Rev-permissive HeLa cells
maintain DDX1 nuclear dominance, specific astrocytic cell
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and nuclear localization of DDX1. Of note, interference
with DDX1 expression resulted in aberrant Rev localization,
shifting from the nucleus to cytoplasm in Cos-1 cells (Fang
et al., 2004). These data, plus the present important
functional studies demonstrating that over-expression of
DDX1 in astrocytes leads to both Rev sub-cellular redis-
tribution and augmentation of HIV-1 production, support the
hypothesis that DDX1 is a critical cell-cofactor for Rev
localization and activity in astrocytes.
The precise mechanisms for DDX1’s cytoplasmic and
nuclear distribution in astrocytes remain to be fully
elucidated. Apparently, cellular factors or a related network
with DDX1 may be key in ‘‘arranging’’ DDX1 distribu-
tion. Secondly, a unique ‘‘isoform’’ of DDX1 expressed in
astrocytes may also be possible. The current DDX1 clone
used in this present study was derived from a retinoblas-
toma cell line that frequently shows genomic amplification
of DDX1 and the related N-myc gene with suggested roles
in oncogenesis (Abdelhaleem, 2004; Godbout and Squire,
1993). Of interest, in a recent article, DDX1 has been
shown in RNA-transporting granules in dendrites of
neurons, together with other related molecules including
DDX3, another member of DEAD-box RNA helicase
family (Kanai et al., 2004). A very recent study revealed
that DDX3 is also required for HIV-1 Rev-RRE nucleo-
cytoplasmic trafficking (Yedavalli et al., 2004), and so
synergistic actions of multiple DEAD-box helicases may
be co-factors in the lentiviral life cycle. Thus, changes in
RNA helicases themselves and/or in the cellular micro-
environment of astrocytes will impact on HIV-1 transcript
processing.
Finally, the mechanism(s) of aberrant of Rev localization
may serve as a molecular key toward understanding unique
astrocyte biology. This may also lead to further under-
standing of potential non-T-cell HIV-1 reservoirs.Materials and methods
Cells
Primary human fetal astrocytes, only low passage (i.e.,
less than two), were obtained from Dr. Brian Wigdahl’s
(Drexel University) and Dr. Avi Nath’s laboratories
(Johns Hopkins University). Human fetal astrocytes,
when confluent to 80%, were split 1:3 or 1:4. Trypsin-
EDTA was used for cell detachment. Growth medium
included: Ham’s F12/DMEM high glucose, fetal calf
serum, Hepes 1 M solution, sodium bicarbonate 7.5% w/v,
penicillin-streptomycin 1, and glutamine. Purity was
analyzed by Cy3-conjugated antibody staining (Sigma
#C-9205) for glial fibrillary acidic protein (GFAP).
HEK293T, HEK293, HeLa, human fetal astrocytes, and
U87MG (human astroglioma cells) were maintained in
DMEM medium with 10% FBS. Jurkat T-cells werecultured in RPMI 1640 with 10% FBS at 37 -C in a 5%
CO2 incubator. All fetal astrocyte studies were approved
by the various universities’ institutional review boards
(IRBs).
Constructs, transfections, and infections
All transfection experiments were performed using
FuGENE 6 (Roche #1814443), and followed the manu-
facture’s recommended protocols with minor changes.
The infection experiments were performed in a Biosafety
Level 3 Laboratory. HIV-1NL4-3 virus stocks were
generated from HEK293T cells transfected with pNL4-3
(3). The procedures for production of pseudotyped HIV-1
[i.e., HIV-1 with amphotropic murine leukemia virus
(MLV) envelope glycoproteins] were the same as
described previously (Canki et al., 2001). The cells were
infected by either wild-type or envelope-pseudotyped
HIV-1 for 2 h. After removal of the infectious medium,
the cells were maintained in standard culture medium
until being harvested the next day. The supernatants were
measured for HIV-1 Gag p24 using an enzyme-linked
immunosorbent assay (ELISA; Zeptometrix). Cellular
RNA was extracted according to the Trizol reagent
protocol (Invitrogen #15596-026) and processed with a
reverse transcription reaction (M-MLV RT. Promega
#BP3208-1). Green fluorescence protein (GFP) and
GFP-Rev fusion constructs were as described (Neumann
et al., 2001).
HIV-1 proviral clones, expressing the luciferase (luc)
gene in the nef open reading frame of HXB2 (X4-tropic),
were used to produce viral stocks after transfection into
U87MG cells (Tokunaga et al., 2001). Normalized quanti-
ties of virus were used to infect U87MG astrocytic-glial
cells constitutively expressing CD4 and CXCR4 on the
surface. Synthetic siRNA duplexes were designed and then
chemically synthesized by Dharmacon Inc. (Lafayette, CO).
The target sites for the siRNA DDX1 and siRNA GFP were
CAAGCCCTCTTTCCTGCCTG (961–980, X70649) and
GCAGCACGACTTCTTCAAG (918–936, U55762),
respectively (Fang et al., 2004).
Primers and PCR conditions
The sizes for unspliced pol, multiply-spliced tat –rev,
tat –rev –nef, and singly-spliced RNA (BSS KPNA) were
196, 173, 146, and ¨400 bp, respectively. The primers used
in the RT-PCR were SCaf.F (5VAAGCTCTATTAGATACA-
GGAGCAGATG A3V)/Scaf.R(5VCCAATTATGTTGACAG
GTGTAGGTCCTA3V) for pol, SC02F (5VAGCCTTAGG-
CATCTCCTATGGCAGGAA3V)/SC52R (5VTAAGTCT-
CTCAAGCGGTGGTAGCTGAA 3V) for tat –rev, SC05F
(5VGAAGAAGCGGAGAC AGCGACGAAGAGCTC3V)/
SC52R for tat –rev –nef, and, BSS (5V GGCTTGCTGA-
AGCGCGCA CGGCAAGAGG3V)/KPNA(5VAGAGTGGT-
GGTTGCTTCCTTCCACACAG3V) for singly-spliced 4.0
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Schwartz et al., 1990). The internal control PCR primers, for
the 361-bp fragment of the ‘‘housekeeping’’ gene rig/S15,
were S15-F (5V TTCCGCAAGTTCACCTACC3V) and S15-
R (5V CGGGCCGGCC ATGCTTTACG3) (Inoue et al.,
1987; Kitagawa et al., 1991). PCR mixtures were prepared
by adding 1.0 Al/20 Al of RT reaction to a total of 20 Al
PCR buffer (10 mM Tris–CL pH8.3, 50 mM KCL, 0.2
mM each dNTP, 4.0 mM MgCL2, 0.01% Gelatin and
0.05% Tween 20 with 0.04 AM of each housekeeping
gene mRNA primer, 0.2 AM of each target primer, 0.4
Units of Taq polymerase; Fisher Scientific). Two thermal
cycle programs were used: 94 -C 5V/30 cycles of 94
-C45–59 -C45–72 -C60/72 -C7V for unspliced/
multiply-spliced, and 94 -C 5V/40 cycles of 94 -C45–61
-C45–72 -C60/72 -C 7V for singly-spliced RNA, with
GeneAmp PCR system 9700 (PE Applied Biosystem). Ten
microliters of each PCR product was applied to a 2%
agarose gel for electrophoresis and than visualized with
ethidium bromide staining.
Semi-quantitative assays of RT-PCR products
The gel photographs were scanned and further analyzed
for density comparison by using IQ Mac v1.2 software
(Molecular Dynamics). The density ratios of viral RNA
bands versus the ‘‘housekeeping’’ gene band served as
standards, according to the known dilution of the samples in
cDNA from HeLa cells.
A mouse anti-DDX1 monoclonal antibody (BD Phar-
mingen) was used at a dilution of 1:200 in immunofluo-
rescence analyses (IFA). The fluorescein isothiocyanate
(FITC)-conjugated anti-mouse IgG (Sigma) was employed
as a second antibody. The cells cultured on chamber
slides were fixed 48 h after transfection with 3.5%
formaldehyde in Dulbecco’s phosphate-buffered saline
(PBS). Incubation in primary and secondary antibodies
was performed for 1 h at 37 -C, followed by extensive
washes with PBS. The cells were then treated with
mounting medium containing 4V, 6-diamidino-2-phenyl-
indole (DAPI; Vector Laboratories, Burlingame, CA). Cells
expressing GFP were processed through similar washing,
fixation, and mounting steps. The fluorescence from these
cells was analyzed via epifluorescence microscopy
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